Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Type

Guidance programme

Advice programme

Showing 51 to 67 of 67

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Intraoperative tests (RD‑100i OSNA system and Metasin test) for detecting sentinel lymph node metastases in breast cancerHTG315
Early and metastatic HER2-positive breast cancer: subcutaneous trastuzumabESNM13
Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancerTA263
Lapatinib or trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone receptor-positive breast cancer that overexpresses HER2TA257
Breast reconstruction using lipomodelling after breast cancer treatmentHTG280
Fulvestrant for the treatment of locally advanced or metastatic breast cancerTA239
Bevacizumab in combination with a taxane for the first-line treatment of metastatic breast cancerTA214
Image-guided radiofrequency excision biopsy of breast lesionsHTG198
Endoscopic mastectomy and endoscopic wide local excision for breast cancerHTG188
Brachytherapy as the sole method of adjuvant radiotherapy for breast cancer after local excisionHTG171
Laparoscopic mobilisation of the greater omentum for breast reconstructionHTG162
Gemcitabine for the treatment of metastatic breast cancerTA116
Image-guided vacuum-assisted excision biopsy of benign breast lesionsHTG100
Endoscopic axillary lymph node retrieval for breast cancerHTG93
Interstitial laser therapy for fibroadenomas of the breastHTG80
Interstitial laser therapy for breast cancerHTG55
Guidance on the use of trastuzumab for the treatment of advanced breast cancerTA34

Results per page

  1. 10
  2. 25
  3. 50
  4. All